Scholarlink

<p>Acute Respiratory Infections (ARIs) are a leading cause of pediatric mortality, with <i>Pseudomonas aeruginosa</i> as a key pathogen. This study evaluated Recombinase Polymerase Amplification (RPA)-ELISA for rapid detection of <i>P. aeruginosa</i> in respiratory samples (<i>n</i> = 101). Compared to Real-Time PCR (98.8% sensitivity, 100% specificity), RPA-ELISA showed 97.6% sensitivity and 90% specificity, detecting pathogens at 41&#xa0;ng/µL within 30&#xa0;min. The method’s simplicity and speed support its use as a screening tool in resource-limited settings, though confirmatory testing remains advised. Respiratory samples (sputum, BAL, throat cultures) were collected from pediatric patients (August–December 2022). <i>P. aeruginosa</i> was identified via culture, biochemical tests, and Real-Time PCR (targeting <i>gyrB</i>). RPA-ELISA was optimized for <i>P. aeruginosa</i> detection using labeled primers/probes. Among 101 samples, 83 (82.2%) were&#xa0;<i>P. aeruginosa</i>. RPA-ELISA demonstrated 97.6% sensitivity (95% CI: 91.7–99.7%) and 90% specificity (95% CI: 55.5–99.7%) compared to Real-Time PCR (98.8% sensitivity, 95% CI: 93.5–100%; 100% specificity, 95% CI: 69.2–100%). The method detected&#xa0;<i>P. aeruginosa</i>&#xa0;at&#xa0;a concentration of 41&#xa0;ng/µL&#xa0;with a 30-min turnaround time. Positive results were indicated by a color change in the ELISA wells, contrasting with negative controls. RPA-ELISA is a promising IM-POCT for <i>P. aeruginosa</i>, offering high sensitivity and rapid results. It is suitable for resource-limited settings but requires confirmatory testing due to moderate specificity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Recombinase Polymerase Amplification (RPA) as an Isothermal Molecular-Point of Care Test (IM-POCT) for Rapid Identification of P. aeruginosa Among Patients with Respiratory Infection

  • 期刊论文

  • 发表日期：

    2025年7月1日

查看全文
  • Reza Azizian,
  • Erfaneh Jafari,
  • Babak Pourakabri,
  • Setareh Mamishi,
  • Saman Hosseinkhani,
  • Reihaneh Hosseinpour Sadeghi

摘要

Acute Respiratory Infections (ARIs) are a leading cause of pediatric mortality, with Pseudomonas aeruginosa as a key pathogen. This study evaluated Recombinase Polymerase Amplification (RPA)-ELISA for rapid detection of P. aeruginosa in respiratory samples (n = 101). Compared to Real-Time PCR (98.8% sensitivity, 100% specificity), RPA-ELISA showed 97.6% sensitivity and 90% specificity, detecting pathogens at 41 ng/µL within 30 min. The method’s simplicity and speed support its use as a screening tool in resource-limited settings, though confirmatory testing remains advised. Respiratory samples (sputum, BAL, throat cultures) were collected from pediatric patients (August–December 2022). P. aeruginosa was identified via culture, biochemical tests, and Real-Time PCR (targeting gyrB). RPA-ELISA was optimized for P. aeruginosa detection using labeled primers/probes. Among 101 samples, 83 (82.2%) were P. aeruginosa. RPA-ELISA demonstrated 97.6% sensitivity (95% CI: 91.7–99.7%) and 90% specificity (95% CI: 55.5–99.7%) compared to Real-Time PCR (98.8% sensitivity, 95% CI: 93.5–100%; 100% specificity, 95% CI: 69.2–100%). The method detected P. aeruginosa at a concentration of 41 ng/µL with a 30-min turnaround time. Positive results were indicated by a color change in the ELISA wells, contrasting with negative controls. RPA-ELISA is a promising IM-POCT for P. aeruginosa, offering high sensitivity and rapid results. It is suitable for resource-limited settings but requires confirmatory testing due to moderate specificity.